从2019年到2023年,65岁以上成年人中用于阿片成瘾的丁丙诺啡使用量上升了70%,尽管在剂量过大的统计数据中,老年人所占比例仍然不足。 Buprenorphine use for opioid addiction rose 70% among adults 65+ from 2019 to 2023, though older adults remain underrepresented in overdose statistics.

缅因监测对医疗保险数据的分析显示,从2019年到2023年,65岁及以上的成年人中阿片类药物成的布普伦诺芬治疗增加了70%,这表明这种趋势正在增长,但仍很小. A Maine Monitor analysis of Medicare data shows a 70% rise in buprenorphine treatment for opioid addiction among adults 65 and older from 2019 to 2023, indicating a growing but still small trend. 保健服务提供者报告说,使用芬太尼和其他非法类阿片的老年病人越来越多,由于监管更加严格,往往在从处方药过渡之后。 Healthcare providers report increasing numbers of older patients using fentanyl and other illicit opioids, often after transitioning from prescription drugs due to tighter regulations. 虽然老年人占人口的23%,但在2023年,他们仅占非致命用药过量的12%,导致国家官员优先考虑年轻人,因为类阿片使用紊乱通常始于青少年期。 While older adults make up 23% of the population, they accounted for only 12% of nonfatal overdoses in 2023, leading state officials to prioritize younger populations, as opioid use disorder typically begins in adolescence. 一些提供者看到人口结构的变化,而另一些提供者则注意到没有明显增加,着重指出了不一致的模式和对治疗吸毒成瘾的老年人方面未充分认识到的挑战的关切。 Some providers see a shift in demographics, while others note no significant increase, highlighting inconsistent patterns and concerns about under-recognized challenges in treating older adults with addiction.